JSK Investments invests in US start-up iSono Health

The investment group JSK Investments, led by Simona Kijonková, has acquired a stake in the American medtech start-up iSono Health. The company is developing ATUSA™, the world's first fully automated, portable and wearable 3D ultrasound system for breast cancer screening. The technology is designed to give women around the world access to quick and easy early detection.

Every year, over 2 million new cases of breast cancer are diagnosed worldwide. Early detection significantly increases the chances of survival.

Automated 3D ultrasound technology for precise diagnoses

ATUSA™ combines portable hardware with intelligent software to automatically capture and analyze ultrasound images. The solution integrates a 3D scanner, a wearable module and a cloud-based platform with AI-supported analysis. Doctors can view the images in real time via desktop, tablet or smartphone. Each scan takes just two minutes and does not require specially trained sonographers.

The system thus enables a precise, painless and fast breast examination that can be used in clinics and radiology centers as well as in the home environment.

Technology with international recognition

iSono Health was awarded the Frost & Sullivan U.S. New Product Innovation Award in 2023, closed a financing round of around USD 5 million in early 2025 and is currently conducting an NIH-funded clinical study to validate its AI technology.

We are delighted to have JSK Investments as a strong international partner. We share a mission to make breast screening accessible, fast and technologically advanced.

Neda Razavi, CEO of iSono Health

"Healthcare is an industry with enormous potential - and the founder story always plays a key role," explains Simona Kijonková, Founder and Managing Partner of JSK Investments. "I come from a country with excellent healthcare, but I know that this is not standard everywhere. That's why I decided to invest in iSono Health - to promote technology that can save lives."

With the entry of JSK Investments, the Czech Republic joins renowned international investors such as Draper Associates and Transform VC to advance the global availability of AI-powered breast screening.

JSK Investment Group was founded in 2017 by Simona Kijonková and Jaromír Kijonka. The family investment vehicle bundles their entrepreneurial activities with a focus on direct investments in the Czech Republic and Europe. The portfolio includes Alensa, one of Europe's largest online retailers for contact lenses and glasses. Packeta, the logistics and tech platform founded by Kijonková, was also part of the holding until 2024.